1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow PF-06835919 High Dose: new trials by email Literature Review of PF-06835919 High Dose trials Research Report on PF-06835919 High Dose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 6-week Safety and PD Study in Adults With NAFLD Placebo, PF-06835919 Low Dose, PF-06835919 High Dose - Non-alcoholic Fatty Liver Disease | Phase 2 | Completed | Pfizer | 53 | 2017-09-27 | 2019-04-04 |
Non-alcoholic Fatty Liver Disease (1)
Pfizer (1)
United States (1)